Table 1.

Baseline patient characteristics

Characteristic	Nab-Paclitaxel plus Gemcitabine (range)
AGE (range)	67 (41–77)
> 70	11 (26,8 %)
SEX
M	18 (43,9 %)
F	23 (56,1 %)
PS (Karnofsky)
100 %	18 (43,9 %)
80–90 %	14 (34.1 %)
60–70 %	9 (21,9 %)
PANCREATIC PRIMARY LOCATION
HEAD	24 (58.5 %)
BODY/TAIL	17 (41.5 %)
SITE OF METASTASIS
Lung	10 (24,3 %)
Node	7 (17 %)
Liver	30 (73,1 %)
Peritoneum	5 (12,2 %)
Bone	1 (2,4 %)
No OF METASTATIC SITES
1	30 (73,1 %)
≥ 2	11 (26,9 %)
BILIARY STENT	9 (21.9 %)
MEDIAN CA19.9	469 U/I (17.4–61546)
PREVIOUS SURGERY	11 (26.8 %)
PREVIOUS ADJUVANT GEMCITABINE	10 (24.3 %)